BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 26774140)

  • 1. Gossypol Reduces Metastasis and Epithelial-Mesenchymal Transition by Targeting Protease in Human Cervical Cancer.
    Hsieh YS; Chu SC; Huang SC; Kao SH; Lin MS; Chen PN
    Am J Chin Med; 2021; 49(1):181-198. PubMed ID: 33371817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atractylodes macrocephala III suppresses EMT in cervical cancer by regulating IGF2BP3 through ETV5.
    Wang M; Meng J; Wang H; Hu H; Hong Y
    J Cell Mol Med; 2024 Feb; 28(4):e18081. PubMed ID: 38358034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b
    Qu N; Meng Y; Zhai J; Griffin N; Shan Y; Gao Y; Shan F
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110967. PubMed ID: 37741126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells.
    Zhang Z; Knobloch TJ; Seamon LG; Stoner GD; Cohn DE; Paskett ED; Fowler JM; Weghorst CM
    Gynecol Oncol; 2011 Nov; 123(2):401-6. PubMed ID: 21831414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin inhibits the growth, migration and invasion of cervical cancer cells by down-regulating IL-17E/IL-17RB.
    Cheng J; Gu CJ; Zhang B; Xie F; Yuan MM; Li MQ; Yu JJ
    Int J Clin Exp Pathol; 2017; 10(9):9341-9351. PubMed ID: 31966806
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Montoya-Gómez A; Tonello F; Spolaore B; Massimino ML; Montealegre-Sánchez L; Castillo A; Rivera Franco N; Sevilla-Sánchez MJ; Solano-Redondo LM; Mosquera-Escudero M; Jiménez-Charris E
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Effect of MiR-375 Regulates YAP1 on the Invasion, Apoptosis, and Epithelial-Mesenchymal Transition of Cervical Cancer HeLa Cells.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9787136. PubMed ID: 38125162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression.
    Effendi WI; Nagano T
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine Receptor A2B Negatively Regulates Cell Migration in Ovarian Carcinoma Cells.
    Campos-Contreras ADR; González-Gallardo A; Díaz-Muñoz M; Vázquez-Cuevas FG
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration
    Gao ZW; Liu C; Yang L; Chen HC; Yang LF; Zhang HZ; Dong K
    Front Genet; 2021; 12():728200. PubMed ID: 34868205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine and paracrine purinergic signaling in the most lethal types of cancer.
    Reyna-Jeldes M; Díaz-Muñoz M; Madariaga JA; Coddou C; Vázquez-Cuevas FG
    Purinergic Signal; 2021 Sep; 17(3):345-370. PubMed ID: 33982134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host CD39 Deficiency Affects Radiation-Induced Tumor Growth Delay and Aggravates Radiation-Induced Normal Tissue Toxicity.
    Meyer AV; Klein D; de Leve S; Szymonowicz K; Stuschke M; Robson SC; Jendrossek V; Wirsdörfer F
    Front Oncol; 2020; 10():554883. PubMed ID: 33194619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome.
    Pietrobono D; Giacomelli C; Marchetti L; Martini C; Trincavelli ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic Signaling in the Hallmarks of Cancer.
    Campos-Contreras ADR; Díaz-Muñoz M; Vázquez-Cuevas FG
    Cells; 2020 Jul; 9(7):. PubMed ID: 32635260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic signaling and tumor microenvironment in cervical Cancer.
    Pfaffenzeller MS; Franciosi MLM; Cardoso AM
    Purinergic Signal; 2020 Mar; 16(1):123-135. PubMed ID: 32170538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The A
    Giacomelli C; Daniele S; Romei C; Tavanti L; Neri T; Piano I; Celi A; Martini C; Trincavelli ML
    Front Pharmacol; 2018; 9():54. PubMed ID: 29445342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine inhibits migration, invasion and induces apoptosis of human cervical cancer cells.
    Gao ZW; Wang HP; Dong K; Lin F; Wang X; Zhang HZ
    Neoplasma; 2016; 63(2):201-7. PubMed ID: 26774140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
    Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
    Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.